These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 30840323)

  • 21. Healthcare costs associated with bevacizumab and cetuximab in second-line treatment of metastatic colorectal cancer.
    Yang H; Yu AP; Wu EQ; Yim YM; Yu E
    J Med Econ; 2011; 14(5):542-52. PubMed ID: 21728912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Geriatric factors associated with overall survival in older patients with metastatic colorectal cancer.
    Dardaine V; Cancel M; Inyambo K; Biogeau J; Sauger C; Lecomte T; Dorval E
    Clin Res Hepatol Gastroenterol; 2024 Feb; 48(2):102280. PubMed ID: 38182006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potentially inappropriate medication use in older patients with breast and colorectal cancer.
    Karuturi MS; Holmes HM; Lei X; Johnson M; Barcenas CH; Cantor SB; Gallick GE; Bast RC; Giordano SH
    Cancer; 2018 Jul; 124(14):3000-3007. PubMed ID: 29689595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of K-Ras mutation rate in metastatic colorectal cancer patients.
    Vincenzi B; Cremolini C; Sartore-Bianchi A; Russo A; Mannavola F; Perrone G; Pantano F; Loupakis F; Rossini D; Ongaro E; Bonazzina E; Dell'Aquila E; Imperatori M; Zoccoli A; Bronte G; De Maglio G; Fontanini G; Natoli C; Falcone A; Santini D; Onetti-Muda A; Siena S; Tonini G; Aprile G
    Oncotarget; 2015 Oct; 6(31):31604-12. PubMed ID: 26384309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Real-world Treatment Patterns Among Patients With Colorectal Cancer Treated With Trifluridine/Tipiracil and Regorafenib.
    Patel AK; Duh MS; Barghout V; Yenikomshian MA; Xiao Y; Wynant W; Tabesh M; Fuchs CS
    Clin Colorectal Cancer; 2018 Sep; 17(3):e531-e539. PubMed ID: 29803544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Primary Tumor Site on Bevacizumab Efficacy in Metastatic Colorectal Cancer.
    Wong HL; Lee B; Field K; Lomax A; Tacey M; Shapiro J; McKendrick J; Zimet A; Yip D; Nott L; Jennens R; Richardson G; Tie J; Kosmider S; Parente P; Lim L; Cooray P; Tran B; Desai J; Wong R; Gibbs P
    Clin Colorectal Cancer; 2016 Jun; 15(2):e9-e15. PubMed ID: 26968236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome of chemotherapy with or without targeted agents in metastatic colorectal cancer patients with deficient DNA mismatch repair: A single center, cohort study.
    Yu Y; Ying J; Zhang W; Li W; Sun Y; Yang L; Cui C; Zeng Y; Zhou A
    Asia Pac J Clin Oncol; 2019 Jun; 15(3):128-135. PubMed ID: 30693649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prolonged survival of patients with metastatic colorectal cancer following first-line oxaliplatin-based chemotherapy with molecular targeting agents and curative surgery.
    Shitara K; Matsuo K; Kondo C; Takahari D; Ura T; Inaba Y; Yamaura H; Sato Y; Kato M; Kanemitsu Y; Komori K; Ishiguro S; Sano T; Shimizu Y; Muro K
    Oncology; 2011; 81(3-4):167-74. PubMed ID: 22057124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness and safety of aflibercept for metastatic colorectal cancer: retrospective review within an early access program in Spain.
    Feliu J; Díez de Corcuera I; Manzano JL; Valladares-Ayerbes M; Alcaide J; García García T; Vera R; Sastre J
    Clin Transl Oncol; 2017 Apr; 19(4):498-507. PubMed ID: 27718155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Secondary Metastases Resection After Bevacizumab Plus Irinotecan-Based Chemotherapy in First-Line Therapy of Metastatic Colorectal Cancer in a Real-Life Setting: Results of the ETNA Cohort.
    Rouyer M; Smith D; Laurent C; Becouarn Y; Guimbaud R; Michel P; Tubiana-Mathieu N; Balestra A; Jové J; Robinson P; Noize P; Moore N; Ravaud A; Fourrier-Réglat A;
    Target Oncol; 2016 Feb; 11(1):83-92. PubMed ID: 26298481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome of Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Mayo Clinic Experience.
    Jin Z; Sanhueza CT; Johnson B; Nagorney DM; Larson DW; Mara KC; Harmsen WC; Smyrk TC; Grothey A; Hubbard JM
    Oncologist; 2018 Sep; 23(9):1083-1091. PubMed ID: 29674439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perioperative therapy in metastatic colorectal cancer: Pattern of use and survival outcomes.
    Alese OB; Zakka K; Huo X; Jiang R; Shaib WL; Akce M; Behera M; Sullivan P; Wu C; El-Rayes BF
    J Surg Oncol; 2021 Feb; 123(2):596-605. PubMed ID: 33125756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association Between Use of Anticancer Drugs and Cardiovascular Disease-Related Hospitalization in Metastatic Colorectal Cancer: Insights From a Population-Based Study, the Anticancer Vigilance of Cardiac Events Study.
    Dolladille C; Launoy G; Bouvier V; Salem JE; Legallois D; Milliez P; Sassier M; Lobbedez T; Guittet L; Alexandre J
    Am J Epidemiol; 2021 Feb; 190(3):376-385. PubMed ID: 32964219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes of Older Patients (≥ 70 Years) Treated With Targeted Therapy in Metastatic Chemorefractory Colorectal Cancer: Retrospective Analysis of NCIC CTG CO.17 and CO.20.
    Wells JC; Tu D; Siu LL; Shapiro JD; Jonker DJ; Karapetis C; Simes J; Liu G; Price TJ; Tebbutt NC; O'Callaghan CJ
    Clin Colorectal Cancer; 2019 Mar; 18(1):e140-e149. PubMed ID: 30595557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Relationship Between Health-Related Quality of Life and Survival in Metastatic Colorectal Cancer Patients Treated With Korean Medicine.
    Park S; Eo W; Lee S
    Integr Cancer Ther; 2018 Mar; 17(1):65-72. PubMed ID: 28024424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patterns of treatment with chemotherapy and monoclonal antibodies for metastatic colorectal cancer in Western Europe.
    Zhao Z; Pelletier E; Barber B; Bhosle M; Wang S; Gao S; Klingman D
    Curr Med Res Opin; 2012 Feb; 28(2):221-9. PubMed ID: 22171947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Durable complete responses in metastatic colorectal cancer treated with chemotherapy alone.
    Ferrarotto R; Pathak P; Maru D; Agarwal A; Overman M; Hoff PM; Kopetz S
    Clin Colorectal Cancer; 2011 Sep; 10(3):178-82. PubMed ID: 21855039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrating geriatric assessment in the first line chemotherapy treatment in older patients with metastatic colorectal cancer: Results of a prospective observational cohort study (AVAPLUS).
    Decoster L; Kenis C; Naessens B; Houbier G; De Man M; Lambrecht G; Monsaert E; Moons V; Vergauwe P; Prenen H; Van Cutsem E; Wildiers H
    J Geriatr Oncol; 2018 Mar; 9(2):93-101. PubMed ID: 29133190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metastatic Colorectal Cancer in Young Adults: A Study From the South Australian Population-Based Registry.
    Vatandoust S; Price TJ; Ullah S; Roy AC; Beeke C; Young JP; Townsend A; Padbury R; Roder D; Karapetis CS
    Clin Colorectal Cancer; 2016 Mar; 15(1):32-6. PubMed ID: 26341410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patterns of care and outcomes for elderly patients with metastatic colorectal cancer in Australia.
    Parakh S; Wong HL; Rai R; Ali S; Field K; Shapiro J; Wong R; Nott L; Gibbs P; Yip D
    J Geriatr Oncol; 2015 Sep; 6(5):387-94. PubMed ID: 26190441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.